Cited by 241Liver Disease and TransplantationAbdominal vascular conditions and treatmentsAntifungal resistance and susceptibility

β‐Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta‐analysis

Senzolo, Marco, Cholongitas, Evangelos, Burra, Patrizia, Leandro, Gioacchino, Thalheimer, Ulrich, Patch, David, Burroughs, Andrew Kenneth·2009·Liver International

Abstract

Introduction: Bacterial infections have been hypothetized to be a trigger of variceal bleeding in cirrhotic patients and β‐blockers may have a protective effect by decreasing bacterial translocation, reducing portal pressure. The aim of our study was to evaluate the possible role of β‐blockers in preventing spontaneous bacterial peritonitis (SBP) in patients with liver cirrhosis and ascites. Materials and Methods: Extensive search of the literature including randomized controlled trial (RCT) and non‐RCT of primary and secondary prophylaxis for variceal bleeding in cirrhotics using β‐blockers were evaluated. We performed a meta‐analysis using the occurrence of SBP as endpoint in all the studies, using the random effect model. Results: Three RCT and three retrospective studies in which β‐blockers were evaluated against no treatment for the prevention of SBP in ascitic cirrhotics were included. There was a statistically significant difference of 12.1%, P<0.001 in favour of propranolol in preventing SBP, which was confirmed by sensitivity analysis evaluating only RCTs (7.8% difference). The effect was still present when haemodynamic responders were compared with non‐responders. Conclusions: This analysis suggests a role of β‐blockers in preventing SBP in ascitic cirrhotics, independent of haemodynamic response. Further formal RCTs are needed to confirm this finding.

Integrity signals

Registry

Crossref · 10.1111/j.1478-3231.2009.02038.x

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nonselective β-adrenergic blockers decrease intestinal transit time and reduce intestinal bacterial overgrowth, intestinal permeability and bacterial translocation in experimental cirrhosis and patients.

    “Accordingly, nonselective β-adrenergic blockers decrease intestinal transit time and reduce intestinal bacterial overgrowth, intestinal permeability and bacterial translocation in experimental models of cirrhosis as well as in patients153–157.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Senzolo, M., Cholongitas, E., Burra, P., Leandro, G., Thalheimer, U., Patch, D., & Burroughs, A. K.
Affiliations
  • University of Padua (IT)
  • Gastroenterology Hospital "Saverio de Bellis" (IT)
  • The Royal Free Hospital (GB)
Corresponding author
Burroughs, Andrew Kenneth
Venue
Liver International
Publisher
Wiley
Published
2009-08-03
Volume
29
Issue
8
Pages
1189-1193
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W1994589471
Cited by
241
References
30
Citations by year
2026: 1 · 2025: 9 · 2024: 12 · 2023: 14 · 2022: 17 · 2021: 17 · 2020: 17 · 2019: 14 · 2018: 14 · 2017: 15 · 2016: 16 · 2015: 24 · 2014: 20 · 2013: 11 · 2012: 9
FWCI
8.40
Type
journal article
Language
en
Open access
closed
Locations
  • Liver International (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Keywords
beta-blockers, spontaneous bacterial peritonitis, liver cirrhosis, ascites, propranolol, variceal bleeding, bacterial translocation, portal hypertension, prophylaxis
MeSH terms
Adrenergic beta-Antagonists, Bacterial Infections, Esophageal and Gastric Varices, Gastrointestinal Hemorrhage, Humans, Liver Cirrhosis, Peritonitis, Propranolol, Randomized Controlled Trials as Topic, Databases, Bibliographic, Bacterial Translocation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review